Brame Glenn P 4
4 · PORTOLA PHARMACEUTICALS INC · Filed Feb 26, 2020
Insider Transaction Report
Form 4
Brame Glenn P
SVP, Technical Operations
Transactions
- Award
Performance Stock Unit
2020-02-24+73,125→ 73,125 totalExp: 2023-02-24→ Common Stock (73,125 underlying)
Footnotes (5)
- [F1]Each performance stock unit (PSU) represents a contingent right to receive one (1) share of the Issuer's common stock.
- [F2]One-third of the PSUs will be earned one or after the one (1) year anniversary of the grant date of February 24, 2020 and when the average closing price of the Issuer's Common Stock on the Nasdaq Global Select Market appreciates 50% per share from the grant date closing price of Issuer's Common Stock on the Nasdaq Global Market over a period of twenty (20) consecutive trading days. The closing price of the Issuer's Common Stock on the Nasdaq Global Market on February 24, 2020 was $13.06.
- [F3]One-third of the PSUs will be earned on or after the two (2) year anniversary of the grant date of February 24, 2020 and when the average closing price of the Issuer's Common Stock on the Nasdaq Global Select Market appreciates 100% per share from the grant date closing price of the Issuer's Common Stock on the Nasdaq Global Select Market over a period of twenty (20) consecutive trading days. The closing price of the Issuer's Common Stock on the Nasdaq Global Market on February 24, 2020 was $13.06.
- [F4]One-third of the PSUs will be earned on the three (3) year anniversary of the grant date of February 24, 2020 and when the average closing price of the Issuer's Common Stock on the Nasdaq Global Select Market appreciates 150% per share from the grant date closing price of the Issuer's Common Stock on the Nasdaq Global Select Market over a period of twenty (2) consecutive trading days. The closing price of the Issuer's Common Stock on the Nasdaq Global Market on February 24, 2020 was $13.06.
- [F5]Any PSUs not yearned on the three (3) year anniversary of the grant date will expire.